Idera Pharmaceuticals

$2.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (+1.91%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell IDRA and other stocks, options, and ETFs commission-free!

About IDRA

Idera Pharmaceuticals, Inc. Common Stock, also called Idera Pharmaceuticals, is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. Read More The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Cambridge, MA. The listed name for IDRA is Idera Pharmaceuticals, Inc. Common Stock.

Employees
36
Headquarters
Exton, Pennsylvania
Founded
1989
Market Cap
74.97M
Price-Earnings Ratio
Dividend Yield
Average Volume
125.71K
High Today
$2.16
Low Today
$2.10
Open Price
$2.10
Volume
68.05K
52 Week High
$2.95
52 Week Low
$0.813

Collections

IDRA Earnings

-$0.46
-$0.23
-$0.01
$0.22
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 5, After Hours

You May Also Like